Krystal Biotech, Inc. (KRYS) Social Stream

Featured Post From StockTwits About KRYS

$ARCT Yeah CF drug CTA bumped a bit. OTC got delayed like a month. Typical. Believe this and $KRYS are undervalued plays on CF. Translate Bio’s mRNA lead candidate for CF had less than encouraging to results. Their other next is yet to go into IND enabling studies. Arrowhead had a blow with safety concerns for their drug. Krystal will be “in the lead” with their drug entering Phase 1 this quarter and Arcturus is next, now early 2022. Different approaches. Early, but I have to imagine that Vertex will approach someone early on.

Krystal Bio is one of my favorites, if not my favorite going into Q4, 2 awesome catalysts.

What Else are KRYS Traders Talking About?

Other tickers frequently mentioned alongside KRYS is ARCT.